Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Laropiprant> ?p ?o }
- Laropiprant type Chemical.
- Laropiprant type Company.
- Laropiprant type Drug.
- Laropiprant type Group.
- Laropiprant type Heterocycle.
- Laropiprant type Organofluoride.
- Laropiprant type Organohalide.
- Laropiprant type Redirect.
- Laropiprant type Organofluoride.
- Laropiprant type Organohalide.
- Laropiprant type ChemicalObject.
- Laropiprant type Thing.
- Laropiprant type Q8386.
- Laropiprant comment "Laropiprant (INN) was a drug used in combination with niacin to reduce blood cholesterol (LDL and VLDL) that is no longer sold, due to increases in side-effects with no cardiovascular benefit. Laropiprant itself has no cholesterol lowering effect, but it reduces facial flushes induced by niacin. Merck & Co. planned to market this combination under the trade names Cordaptive in the US and Tredaptive in Europe. Both brands contained 1000 mg of niacin and 20 mg of laropiprant in each tablet.".
- Laropiprant label "Laropiprant".
- Laropiprant sameAs Q412291.
- Laropiprant sameAs Tredaptive.
- Laropiprant sameAs Laropiprant.
- Laropiprant sameAs laropiprant.
- Laropiprant sameAs m.04g1pwn.
- Laropiprant sameAs Laropiprant.
- Laropiprant sameAs Laropiprant.
- Laropiprant sameAs Q412291.
- Laropiprant wasDerivedFrom Laropiprant?oldid=707011718.
- Laropiprant depiction Laropiprant.png.
- Laropiprant isPrimaryTopicOf Laropiprant.
- Laropiprant name "Niacin/laropiprant".